These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6181054)

  • 1. Microinjection of interferon and 2',5'-oligoadenylate into mouse L cells and their effects on virus growth.
    Higashi Y; Sokawa Y
    J Biochem; 1982 Jun; 91(6):2021-8. PubMed ID: 6181054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity towards VSV and Mengo virus of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P; Huez G; Verhaegen-Lewalle M; De Clercq E; Torrence P; Content J
    Prog Clin Biol Res; 1985; 202():141-6. PubMed ID: 3008170
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P; Huez G; Verhaegen-Lawalle M; De Clercq E; Imai J; Torrence P; Content J
    FEBS Lett; 1986 Mar; 198(2):326-32. PubMed ID: 2420642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
    Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
    J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
    Mittnacht S; Jacobsen H
    Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
    Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells.
    Williams BR; Golgher RR; Brown RE; Gilbert CS; Kerr IM
    Nature; 1979 Dec; 282(5739):582-6. PubMed ID: 95208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of L cells persistently infected with VSV: factors involved in the regulation of persistent infection.
    Nishiyama Y
    J Gen Virol; 1977 May; 35(2):265-79. PubMed ID: 195007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of RNABP, an RNA binding protein that associates with RNase L.
    Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
    J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of interferon action III--significance of pppA2'p5'A2'p5'A in the antiviral action of interferon.
    Liu XY; Yao K; Zhou YX; Jin JR; Wen YM; Lou YC; Li BL; Wang DB
    Sci Sin B; 1983 Aug; 26(8):809-17. PubMed ID: 6194560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 2'5'-oligoadenylic acid on a mouse cell line partially resistant to interferon.
    Panet A; Czarniecki CW; Falk H; Friedman RM
    Virology; 1981 Oct; 114(2):567-72. PubMed ID: 6170160
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of interferon on two human choriocarcinoma-derived cell lines.
    Vandenbussche P; Kuwata T; Verhaegen-Lewalle M; Content J
    Virology; 1983 Jul; 128(2):474-9. PubMed ID: 6310868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral effects of 2',5'oligoadenylates (2-5As), and related compounds.
    Tominaga A; Saito S; Kohno S; Sakurai K; Hayakawa Y; Noyori R
    Microbiol Immunol; 1990; 34(9):737-47. PubMed ID: 2178211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of interferon on glycoprotein and membrane protein of vesicular stomatitis virus released from murine and simian cells.
    Drebot MA; Lee SH; Rozee KR
    J Interferon Res; 1984; 4(2):167-72. PubMed ID: 6205101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells.
    Hovanessian AG; Meurs E; Montagnier L
    J Interferon Res; 1981 Feb; 1(2):179-90. PubMed ID: 6286803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon induces an antiviral state in ganglioside-deficient transformed mouse fibroblasts.
    Schiffmann D; Koschel K
    Med Microbiol Immunol; 1981; 169(4):281-9. PubMed ID: 6168900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-specific effects of interferon in embryonal carcinoma cells.
    Nilsen TW; Wood DL; Baglioni C
    Nature; 1980 Jul; 286(5769):178-80. PubMed ID: 6157099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of interferon induced transfer of viral resistance between animal cells.
    Blalock JE; Baron S
    J Gen Virol; 1979 Feb; 42(2):363-72. PubMed ID: 217961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
    Bayard B; Bisbal C; Lebleu B
    Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.